Clinical trial
Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation
NCT05519293
Study timeline
Study start (actual)2022-12-15Date precision: day
Registry last updated2024-04-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-small Cell Lung Cancerunresolved
Interventions
H002DRUG
Sponsors & collaborators
RedCloud Biolead sponsor
Parexelcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05519293 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.